Sample Tube DeCappers

NHS Blood and Transplant (NHSBT)contractFind a TenderRef ocds-h6vhtk-068daaProcurement Act 2023planning
View buyer

Estimated value

£500k

goods

Awarded value

Suppliers

0

Lots

1

0 awarded

Published

29 Apr 2026

This is a preliminary market engagement notice

Map the supplier landscape and document your shortlist before opening the tender. The market simulation produces a defensible audit record you can attach to your procurement file.

Run market simulation

Description

Within NHSBT, the Testing function in the Blood Supply Directorate performs a wide range of testing services, these include but are not limited to the large-scale blood grouping and microbiological screening of blood and tissue donations. The Authority has two main laboratories in England, in which approximately 1.9 million blood donations are tested each year. The laboratories are located in Filton (Bristol) and Manchester. Manchester is also the site of a third laboratory, which tests all donations in England for HAV/B19. Each donation collected includes a minimum of 4 x 6mL sample tubes, taken into K2 EDTA tubes which have colour coded caps for identification purposes. The Authority requires automated decapping equipment at each of the Authority’s three Testing laboratories. Decappers must have sufficient capacity to process the daily workload of each laboratory within the required timeframe and with a minimum decapping success rate of 95%. In Filton and Manchester main laboratories, tubes are tested in 3 parallel workstreams, and therefore it is necessary that 70% of all tubes would be decapped within 3 hours. Approximate workload of each site: • Filton Testing: approximately 10,500 sample tubes per day • Manchester Testing: approximately 4,500 sample tubes per day • Manchester HAV/B19: approximately 5000 sample tubes per day. Testing occurs in two waves and does not impact the desired criteria Additional functionality such as sample sorting, recapping and re-racking of tubes would be considered. The Supplier must confirm the In Vitro Diagnostic Medical Devices (as defined by the regulations indicated below) are fit for their intended purposes and are:• CE marked in compliance with either European Commission Directive 98/79/EC on In Vitro Diagnostic Medical Devices (IVDMD) or Regulation (EU) 2017/746, and/or;• Devices must be UKCA marked in compliance with UK Medical Devices Regulations 2002, as amended, from 1st July 2024. To register your interest in this opportunity, please contact jo.murphy@nhsbt.nhs.uk by Friday 15th May 2026.

Scope

Reference
C442477
Total value
£500,000 excluding VAT
£600,000 including VAT
Above the relevant threshold
Commercial tool
Standalone contract
Contract dates
01 Jan 2027 to 31 Dec 2031
Possible extension to 31 Dec 2033
Main category
goods
CPV classifications
33100000